Market revenue in 2024 | USD 39.5 million |
Market revenue in 2030 | USD 50.4 million |
Growth rate | 3.8% (CAGR from 2025 to 2030) |
Largest segment | Breast cancer |
Fastest growing segment | Breast Cancer |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Breast Cancer, Prostate Cancer, Colorectal Cancer, Cervical Cancer, Liver Cancer, Lung Cancer, Blood Cancer, Kidney Cancer |
Key market players worldwide | Abbott Laboratories, Bayer AG, Agilent Technologies Inc, Danaher Corp, Hologic Inc, Qiagen NV, Siemens AG, Sysmex Corp, Becton Dickinson & Co, Roche Holding AG ADR |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to oncology based molecular diagnostics market will help companies and investors design strategic landscapes.
Breast cancer was the largest segment with a revenue share of 21.52% in 2024. Horizon Databook has segmented the Sweden oncology based molecular diagnostics market based on breast cancer, prostate cancer, colorectal cancer, cervical cancer, liver cancer, lung cancer, blood cancer, kidney cancer covering the revenue growth of each sub-segment from 2018 to 2030.
Horizon Databook provides a detailed overview of country-level data and insights on the Sweden oncology based molecular diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Sweden oncology based molecular diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account